The Motley Fool Discussion Boards

Previous Page

Stocks G / Geron Corporation

URL:  http://boards.fool.com/my-end-of-year-reivew-of-gern-28197377.aspx

Subject:  my end of year reivew of GERN Date:  12/31/2009  5:40 PM
Author:  tktrimbath Number:  2121 of 2154

INTRO Here's my semi-annual exercise to see if I remember why I own the stocks I own, and so I can check back and see if their stories have changed. I post in case it helps others too.

Geron
GERN (market cap $0.523B)
Geron is a highly speculative biotech stock because its great potential also entails great risk. The company is pursuing a number of technologies: stem cells, nuclear transfer, telamorase management. All of the technologies are innovative and powerful, but they will also require more than the usual amount of testing, and regulatory agencies typically act more slowly with innovations.

The company